Corcept Therapeutics
CORT
#3600
Rank
โ‚ฌ3.12 B
Marketcap
29,42ย โ‚ฌ
Share price
2.34%
Change (1 day)
-44.65%
Change (1 year)

Corcept Therapeutics (CORT) - P/B ratio

P/B ratio as of March 2026 : 5.74

According to Corcept Therapeutics 's latest financial reports the company has a price-to-book ratio of 4.89121.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Corcept Therapeutics - P/B ratio (from 2004 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-316.37-21.26%
2024-12-318.0922.43%
2023-12-316.6151.66%
2022-12-314.36-28.38%
2021-12-316.084.75%
2020-12-315.8155.51%
2019-12-313.73-32.97%
2018-12-315.57-48.39%
2017-12-3110.8-44.6%
2016-12-3119.5-34%
2015-12-3129.5-132.88%
2014-12-31-89.8-688.73%
2013-12-3115.3560.05%
2012-12-312.31-72.08%
2011-12-318.28-37.09%
2010-12-3113.267.34%
2009-12-317.86161.86%
2008-12-313.00-63.8%
2007-12-318.2966.66%
2006-12-314.9860.13%
2005-12-313.110.9%
2004-12-313.08
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.02 22.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.15 7.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.67-70.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
30.9 439.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.44-5.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
6.39 11.46%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-17.4-403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-1.48-125.79%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.75-69.54%๐Ÿ‡บ๐Ÿ‡ธ USA